Anthropic launches Claude Science workbench with validation from BMS, Novartis, Genentech

According to The Verge and Technology Review, Anthropic announced Claude Science, an AI workbench for pharmaceutical research that consolidates fragmented tools and datasets. The platform received validation from major pharma companies Bristol Myers Squibb, Novartis, and Genentech and targets drug development workflows including scientific figure generation.

Topics

Claude

Sources

This intelligence is sourced automatically from public sources across the web and synthesised by the Prefactor AI pipeline. Stories are reviewed before publication.